| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Ofc Imm Med | Chief Business Development Off
1 company
Benzeno Sharon is a Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corporation. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $4.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Chief Commercial Ofc Imm Med | Sell | 63,103 | $13.17 | $831,066.51 | -18.8% | +22.1% | - | |
| Dec 4, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Sale+OE | 12,604 | $16.85 | $212,377.40 | -4.1% | -5.8% | - | |
| Nov 21, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Sale+OE | 606,402 | $16.73 | $10,144,025.57 | -50.5% | -13.8% | - | |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Sell | 44,665 | $6.98 | $311,792.35 | -5.4% | +23.8% | +98.3% | |
| Mar 5, 2024 | ADPT Adaptive Biotechnologies Corp | Chief Commercial Ofc Imm Med | Sell | 29,390 | $3.44 | $100,994.14 | -4.2% | -12.4% | +112.4% | |
| Mar 7, 2022 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sell | 2,670 | $12.01 | $32,066.70 | -2.5% | -41.9% | -26.5% | |
| Mar 15, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 1,354 | $41.69 | $56,450.70 | -2.8% | -8.7% | -74.9% | |
| Mar 1, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 6,771 | $57.62 | $390,143.07 | -92.3% | -36.7% | -75.4% | |
| Feb 19, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 416 | $61.20 | $25,459.20 | -100% | -42.8% | -78.6% | |
| Feb 16, 2021 | ADPT Adaptive Biotechnologies Corp | Chief Business Development Off | Sale+OE | 16,250 | $64.64 | $1,050,381.36 | -43.9% | -46.4% | -75.9% |